Danaher rises as subsidiary receives emergency nod for rapid SARS-CoV-2 test - InvestingChannel

Danaher rises as subsidiary receives emergency nod for rapid SARS-CoV-2 test

Shares of Danaher (DHR) are slightly higher in a down day for the market after the company’s subsidiary Cepheid announced it has received emergency use authorization from the Food and Drug Administration for Xpert Xpress SARS-CoV-2, a rapid molecular diagnostic test for qualitative detection of the virus causing COVID-19. CEPHEID RECEIVES EUA… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3058097/-Danaher-rises-as-subsidiary-receives-emergency-nod-for-rapid-SARSCoV-test)